Biomarkers Market to be Worth $201.33 Billion by 2031

Biomarkers are either released by the human body in response to various diseases or by organs that are affected by the disease, such as tumors. Biomarkers are being used increasingly to detect several infectious and chronic diseases, such as cancer, neurological disorders, cardiovascular diseases, and others.